Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil
- 1 February 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 117 (2) , 89-92
- https://doi.org/10.1001/archderm.117.2.89
Abstract
A therapeutic response to topical fluorouracil in a patient with large atypical nevus syndrome was presented. Six of the patients'' dysplastic melanocytic nevi were treated with topical fluorouracil. Common acquired melanocytic nevi (4) from normal individuals were also treated. All 6 dysplastic nevi responded with inflammation, ulceration and subsequent disappearance of the lesion, while the 4 control melanocytic nevi remained unchanged. Response may herald an important advance in the therapy of these lesions that are known to be histogenetic precursors of malignant melanoma.This publication has 4 references indexed in Scilit:
- Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'Archives of Dermatology, 1978
- Selective Cytotoxic Effect of Topical 5-FluorouracilArchives of Dermatology, 1963
- EXPERIMENTAL AND CLINICAL USE OF FLUORINATED PYRIMIDINES IN CANCER CHEMOTHERAPY1963
- THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVESProceedings of the National Academy of Sciences, 1958